releases: https://ebjohnson.house.gov/media-center/press-releases/congresswoman-johnson-votes-to-bring-down-prescription-drug-prices-with
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://ebjohnson.house.gov/media-center/press-releases/congresswoman-johnson-votes-to-bring-down-prescription-drug-prices-with | Congresswoman Johnson Votes to Bring Down Prescription Drug Prices with House Passage of H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act | 2019-12-12 | 2019 | 2019-12 | Democrat | House | TX | Eddie Johnson | J000126 | ebjohnson.house.gov | legacy | Washington, DC Today, Rep. Johnson voted to pass H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act, which will help bring down the cost of prescription drugs and level the playing field for American patients who are paying more for their medicines than patients in other countries. This bill also gives Medicare the power to negotiate directly with drug companies. The lower prices that are negotiated by Medicare will be transparent, so that private insurance companies can make the same prices available to their consumers. It also creates a new $2000 out-of-pocket limit on prescription drug costs for Medicare beneficiaries. Constituents in the 30th District are facing skyrocketing prescription drug prices, forcing many to choose between their medications and putting food on the table or meeting other basic needs, said Congresswoman Johnson. That's unacceptable, and it's why I pledged to make this issue one of my top priorities this year. I was proud to vote for H.R.3 today to deliver on that promise. I'm pleased that the bill invests the money it saves into expanding Medicare's benefits to include dental, vision, and hearing; assisting innovation in the search for new cures and treatments; and helping combat the opioid crisis. I urge the Senate to take up and pass H.R.3, and send it to the President's desk for his signature. Over the past decade the price of insulin has increased 197 percent, and Medicare Part D spending on insulin has increased 840 percent. There are 30.3 million Americans living with diabetes, including 2,333,065 people in Texas. Under H.R.3 some commonly used insulins can cost as little as $400 per year. In 2019, an estimated 18,750 women in Texas will be diagnosed with breast cancer. H.R.3 can lower the average total cost of the breast cancer medication Ibrance by 65%. In 2019, an estimated 4,820 people in Texas will be diagnosed with leukemia. H.R.3 can lower the average total cost of the leukemia medication Tasigna by 71%. -continued- In 2019, an estimated 10,660 people in Texas will be diagnosed with prostate cancer. H.R.3 can lower the average total cost of the prostate cancer medication Zytiga by 66%. The 2018 Arthritis Foundation tabulations revealed that 19.8% of Texas residents have arthritis, and H.R.3 can lower their total costs on most arthritis drugs from about $40,000 to $10,000 per year. The 2018 Centers for Disease Control and Prevention tabulations showed about 7.3% or 1,543,064 Texas residents live with asthma. H.R.3 can lower their total costs on most asthma drugs from about $1,400 to $270 per year. In 2015, 4,358 Texas residents were diagnosed with HIV, and H.R.3 can lower their total costs on most HIV drugs from about $15,000 to $6,000 per year. ### | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |